General Information of DTT (ID: TTV298Y)

DTT Name Calmodulin-dependent kinase II (CAMKK2) DTT Info
Gene Name CAMKK2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Patented Agent(s)
Investigative Drug(s)
3 Patented Agent(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
CQ7 DMXP073 N. A. N. A. Patented [1]
US9623028, Compound 101 DM6F7M2 N. A. N. A. Patented [1]
US9623028, Compound 79 DMMSHX4 N. A. N. A. Patented [1]
------------------------------------------------------------------------------------
2 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID22136433C20 DMI8217 Discovery agent N.A. Investigative [2]
STO609 DMZSOG2 Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof. US9623028.
2 7,8-dichloro-1-oxo-beta-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes. J Med Chem. 2012 Jan 12;55(1):403-13.
3 STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase. J Biol Chem. 2002 May 3;277(18):15813-8.